FDA Pre-Submission Filed for Cardio inCode-SCORE
FDA Pre-Submission Filed for Cardio inCode-SCORE Commencement of regulatory pathway for U.S. market approval GlobeNewswire January 11, 2022 OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its Pre-Submission for Cardio inCode-SCORE with the...